VisEn Medical
acquired
acquired
Stage
About
VisEn Medical, founded in 2005, developed in vivo molecular imaging systems and fluorescent imaging reagents for cancer, cardiovascular, skeletal and pulmonary applications. The company was acquired by PerkinElmer in 2010.
Explore VisEn Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.